taurine has been researched along with Lung Neoplasms in 27 studies
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Moreover, currently used chemotherapeutics have severe toxic side effects." | 5.38 | The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. ( Arlt, MJ; Banke, IJ; Bertz, J; Born, W; Ehrensperger, F; Fuchs, B; Puskas, GJ; Rentsch, KM; Steinmann, P; Walters, DK, 2012) |
| "After TN treatment of mesothelioma cells, Akt but not extracellular signal-regulated kinase (Erk) 1/2 activity is inhibited a in time- and dose-dependent manner." | 5.35 | Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma. ( Aceto, N; Barbone, D; Bertino, P; Gaudino, G; Manzo, L; Mutti, L; Porta, C; Tassi, G, 2009) |
| "Taurolidine has significant antineoplastic activity against MM in vitro and in vivo, in part, due to tumor cell apoptosis." | 5.32 | The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. ( Calabresi, P; Monfils, B; Nici, L, 2004) |
| " The aim of this prospective study was to observe the influence of long-term intravenous taurolidine on the development of lung metastases after intravenous injection of colon adenocarcinoma cells." | 3.75 | Taurolidine in the prevention and therapy of lung metastases. ( Beshay, M; Bilici, M; Gazdhar, A; Gugger, M; Hoksch, B; Rufer, B; Schmid, RA, 2009) |
| " Moreover, currently used chemotherapeutics have severe toxic side effects." | 1.38 | The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. ( Arlt, MJ; Banke, IJ; Bertz, J; Born, W; Ehrensperger, F; Fuchs, B; Puskas, GJ; Rentsch, KM; Steinmann, P; Walters, DK, 2012) |
| "After TN treatment of mesothelioma cells, Akt but not extracellular signal-regulated kinase (Erk) 1/2 activity is inhibited a in time- and dose-dependent manner." | 1.35 | Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma. ( Aceto, N; Barbone, D; Bertino, P; Gaudino, G; Manzo, L; Mutti, L; Porta, C; Tassi, G, 2009) |
| "Taurolidine has significant antineoplastic activity against MM in vitro and in vivo, in part, due to tumor cell apoptosis." | 1.32 | The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. ( Calabresi, P; Monfils, B; Nici, L, 2004) |
| "We examined chromosome aberrations and plasma levels of the drug in two groups of patients receiving either a single dose of 130 mg/m2 or 40 mg/m2 on 3 consecutive days." | 1.29 | Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose. ( Ellman, M; Gunnarsson, PO; Hansen, HH; Hansson, K; Hartley-Asp, B; Polacek, J; Vibe-Petersen, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (29.63) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Xu, Y | 1 |
| Ma, L | 1 |
| Yu, K | 1 |
| Niu, Y | 1 |
| Xu, X | 1 |
| Shi, Y | 1 |
| Guo, S | 1 |
| Xue, X | 1 |
| Wang, Y | 1 |
| Qiu, S | 1 |
| Cui, J | 1 |
| Wang, H | 1 |
| Tian, X | 1 |
| Miao, Y | 1 |
| Meng, F | 1 |
| Qiao, Y | 1 |
| Yu, Y | 1 |
| Wang, J | 1 |
| Chen, W | 1 |
| Li, Q | 1 |
| Hou, R | 1 |
| Liang, H | 1 |
| Zhang, Y | 2 |
| Yang, Y | 1 |
| Ping, Y | 1 |
| Shan, J | 1 |
| Liu, Y | 1 |
| Liu, F | 1 |
| Wang, L | 2 |
| Liu, Z | 1 |
| Li, J | 1 |
| Yue, D | 1 |
| Chen, X | 1 |
| Zhu, S | 2 |
| Han, X | 2 |
| Yang, R | 2 |
| Tian, Y | 2 |
| Zhang, Q | 2 |
| Wu, Y | 2 |
| Dong, S | 2 |
| Zhang, B | 2 |
| Deng, Y | 1 |
| Li, H | 1 |
| Tang, Y | 1 |
| Holm, JB | 1 |
| Grygorczyk, R | 1 |
| Lambert, IH | 2 |
| Thorsteinsdottir, UA | 1 |
| Thorsteinsdottir, M | 1 |
| Aceto, N | 1 |
| Bertino, P | 1 |
| Barbone, D | 1 |
| Tassi, G | 1 |
| Manzo, L | 1 |
| Porta, C | 1 |
| Mutti, L | 1 |
| Gaudino, G | 1 |
| Hoksch, B | 1 |
| Rufer, B | 1 |
| Gazdhar, A | 1 |
| Bilici, M | 1 |
| Beshay, M | 1 |
| Gugger, M | 1 |
| Schmid, RA | 1 |
| Arlt, MJ | 2 |
| Walters, DK | 1 |
| Banke, IJ | 1 |
| Steinmann, P | 1 |
| Puskas, GJ | 1 |
| Bertz, J | 1 |
| Rentsch, KM | 1 |
| Ehrensperger, F | 1 |
| Born, W | 2 |
| Fuchs, B | 2 |
| Braumann, C | 1 |
| Pfirrmann, RW | 1 |
| TURNER, FP | 1 |
| BRUM, VC | 1 |
| PAQUETTE, WW | 1 |
| WELDEN, RB | 1 |
| Nici, L | 1 |
| Monfils, B | 1 |
| Calabresi, P | 1 |
| Van den Hout, BM | 1 |
| Taal, BG | 1 |
| Gortzak, E | 1 |
| Zoetmulder, FA | 1 |
| Boot, H | 1 |
| Kirk, K | 1 |
| Kirk, J | 1 |
| Hartley-Asp, B | 1 |
| Hansson, K | 1 |
| Vibe-Petersen, J | 4 |
| Hansen, HH | 5 |
| Polacek, J | 1 |
| Ellman, M | 1 |
| Gunnarsson, PO | 1 |
| Bach, F | 3 |
| Sørensen, JB | 2 |
| Dombernowsky, P | 2 |
| Gatzemeier, U | 1 |
| Drings, P | 1 |
| Edler, L | 1 |
| Fiebig, HH | 1 |
| Hinke, A | 1 |
| Rieche, K | 1 |
| Tessen, HW | 1 |
| Pedersen, AG | 1 |
| Smyth, J | 1 |
| Pratesi, G | 1 |
| Savi, G | 1 |
| Tew, KD | 1 |
| Dean, SW | 1 |
| Gibson, NW | 1 |
| Roed, H | 1 |
| Vindeløv, LL | 1 |
| Spang-Thomsen, M | 1 |
| Christensen, IJ | 1 |
| Heaf, JG | 1 |
| Hansen, M | 1 |
| Rivera, S | 1 |
| López-Soriano, FJ | 1 |
| Azcón-Bieto, J | 1 |
| Argilés, JM | 1 |
| Kimura, S | 1 |
| Yoshida, I | 1 |
| Sasaki, I | 1 |
| Ueda, H | 1 |
1 trial available for taurine and Lung Neoplasms
| Article | Year |
|---|---|
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Follow-Up Studies; Germany, | 1990 |
26 other studies available for taurine and Lung Neoplasms
| Article | Year |
|---|---|
Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Exosomes; Ferroptosis; Humans; Lung Neoplasms; Mice; Proteomics; RN | 2022 |
An integrated metabonomics study to reveal the inhibitory effect and metabolism regulation of taurine on breast cancer.
Topics: Animals; Arginine; Breast Neoplasms; Choline; Female; Glutamic Acid; Histidine; Humans; Isoleucine; | 2022 |
Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cyt | 2023 |
Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
Topics: Animals; Arachidonic Acid; Biomarkers; Chromatography, High Pressure Liquid; Linoleic Acid; Lung Neo | 2023 |
Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
Topics: Animals; Arachidonic Acid; Biomarkers; Chromatography, High Pressure Liquid; Linoleic Acid; Lung Neo | 2023 |
Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
Topics: Animals; Arachidonic Acid; Biomarkers; Chromatography, High Pressure Liquid; Linoleic Acid; Lung Neo | 2023 |
Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
Topics: Animals; Arachidonic Acid; Biomarkers; Chromatography, High Pressure Liquid; Linoleic Acid; Lung Neo | 2023 |
The Effect of Suppression Taurine on Relocation and Epithelial-Mesenchymal Transition in Mankind Lung Cancer Cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Lung Ne | 2021 |
Volume-sensitive release of organic osmolytes in the human lung epithelial cell line A549: role of the 5-lipoxygenase.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenocarcinoma; Adenosine Triphosphate; Amino Acid | 2013 |
Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells.
Topics: 4-Butyrolactone; Apoptosis; Arachidonate 5-Lipoxygenase; bcl-2-Associated X Protein; Cell Cycle; Cel | 2016 |
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma.
Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Cells, Cultured; DNA; Fibroblasts; H | 2009 |
Taurolidine in the prevention and therapy of lung metastases.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Lung Neoplasms; | 2009 |
The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Female | 2012 |
Taurolidine: Mode of administration in mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Female | 2012 |
Taurolidine: mode of administration in mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Female | 2012 |
THE URINARY EXCRETION OF FREE TAURINE IN ACUTE AND CHRONIC DISEASE, FOLLOWING SURGICAL TRAUMA, AND IN PATIENTS WITH ACUTE ALCOHOLISM.
Topics: Adrenal Cortex Hormones; Alcoholism; Biliary Tract; Biomedical Research; Cholecystitis; Cholelithias | 1964 |
The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Topics: Amino Acid Chloromethyl Ketones; Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Body Weight; | 2004 |
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; | 1995 |
Volume-regulatory taurine release from a human lung cancer cell line. Evidence for amino acid transport via a volume-activated chloride channel.
Topics: Amino Acids; Biological Transport; Chloride Channels; Colforsin; Humans; Iodides; Lung Neoplasms; Ni | 1993 |
Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.
Topics: Antineoplastic Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Administration | 1996 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female | 1990 |
TCNU in adenocarcinoma of the lung: a phase II study with divided doses.
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Nitrosourea Compounds; Taurin | 1990 |
A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; | 1989 |
Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor.
Topics: Animals; Carmustine; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1989 |
The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines.
Topics: Animals; Cell Line; Cell Survival; DNA, Neoplasm; Glutathione Reductase; Humans; Lomustine; Lung Neo | 1987 |
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
Topics: Carcinoma, Small Cell; Carmustine; Cell Cycle; Cell Line; Colony-Forming Units Assay; Drug Evaluatio | 1987 |
Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
Topics: Adenocarcinoma; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Lung Neoplasms | 1988 |
Blood amino acid compartmentation in mice bearing Lewis lung carcinoma.
Topics: Amino Acids; Animals; Erythrocytes; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimenta | 1987 |
[Use of taurine in radiation therapy of pulmonary cancer].
Topics: Aged; Amino Acids; Blood Cell Count; Blood Platelets; Cobalt Isotopes; Female; Humans; Leukocyte Cou | 1971 |